Common Contracts
4 similar null contracts by Aileron Therapeutics Inc, Athene Holding LTD, Augmedix, Inc., HCI Group, Inc.
HCI Group, Inc. 1,000,000 Shares of Common Stock Underwriting AgreementHCI Group, Inc. • December 7th, 2023 • Fire, marine & casualty insurance • New York
AUGMEDIX, INC. Common Stock, par value $0.0001 per share Form of Underwriting AgreementAugmedix, Inc. • October 4th, 2021 • Services-business services, nec • New York
Augmedix, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of [ ● ] shares (the “Firm Securities”) and, at the election of the Underwriters, up to [ ● ] additional shares (the “Optional Securities”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”). To the extent that you are the only Underwriter, all references to “each Underwriter,” “the Underwriters” or “Representative” shall refer to just you.
AILERON THERAPEUTICS, INC. Common Stock, par value $0.001 per share Underwriting AgreementAileron Therapeutics Inc • June 5th, 2020 • Pharmaceutical preparations • New York
Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of 9,090,910 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 1,363,636 additional shares (the “Optional Securities”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”). To the extent that you are the only Underwriter, all references to “each Underwriter,” “the Underwriters” or “Representative” shall refer to just you.
Athene Holding Ltd. Underwriting AgreementAthene Holding LTD • January 12th, 2018 • Life insurance
Athene Holding Ltd., an exempted company organized under the laws of Bermuda (the “Company”), proposes, upon the terms and conditions set forth in this agreement (this “Agreement”), to issue and sell to Barclays Capital Inc., Goldman Sachs & Co. LLC, Wells Fargo Securities, LLC and the other several underwriters named in Schedule I hereto (the “Underwriters”), for whom Barclays Capital Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC are acting as representatives (in such capacity, the “Representatives”), $1,000,000,000 in aggregate principal amount of its 4.125% Senior Notes due 2028 (the “Notes”). The Notes will have terms and provisions that are summarized in the Pricing Disclosure Package and Prospectus (each as defined below). The Notes are to be issued pursuant to an Indenture, dated January 12, 2018 (the “Base Indenture”), as supplemented by the First Supplemental Indenture, dated January 12, 2018 (the “Supplemental Indenture”; the Base Indenture, as supplemented by
